Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Misuse of Topical...

    Misuse of Topical Steroid Skin Creams: Delhi HC notice to CDSCO

    Written by Ruby Khatun Khatun Published On 2017-11-23T12:37:47+05:30  |  Updated On 14 Aug 2021 1:29 PM IST

    New Delhi: The Delhi High Court on Wednesday sought the Centre's response on a plea seeking direction to ensure that no topical medications which contain a "cocktail of harmful steroids" are sold without a valid prescription.


    Expressing concern over the issue, a Bench of Acting Chief Justice Gita Mittal and Justice C. Hari Shankar issued a notice to the government and the Central Drug Standards and Control Organisation (CDSCO). It directed the authorities to place their stand before the court before the next date of hearing on January 23.


    The public interest litigation (PIL), filed by the Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), has sought a ban on manufacture and sale of several skin creams containing steroids being marketed for skin conditions like pigmentation, itching, fairness, and inflammation.


    The IADVL has also sought a high-level enquiry into how the CDSCO granted approval for commercial manufacture, use and sale of hazardous as well as irrational and unscientific steroid combinations, and also ordering prosecution of the officers concerned.


    The plea has contended that the government has to curb the menace of abuse of certain drugs used in the treatment of skin diseases affecting the health of millions in India by enforcing the provisions of Drugs and Cosmetics Act.


    "Unchecked and unregulated manufacturing and sale of irrational, unscientific and hazardous corticosteroids, either in form of a single molecule or in combination with other antifungals or antibacterials, has caused serious adverse effects on the health of millions of Indians," the PIL said. It stated that potent topical corticosteroids are being misused in the country in the name of treating bacterial or fungal infections, lightening skin colour for fairer complexion, suppressing itchy or painful skin rashes, regardless of their underlying cause.


    "Some major adverse effects are growth retardation in infants and children, Cushing's syndrome, suppression of hypothalamic pituitary adrenal axis, acute adrenal insufficiency, severe hard to treat steroid modified fungal infection of the groin and other body areas, male genital dermatophytosis, topical steroid damaged face," it said.


    It also said that supposedly herbal creams such as Meglow Premium fairness cream and Pearl Beauty Whitening fairness cream also contained steroids.


    "In spite of the fact that these drugs can cause such serious adverse effects, they are sold without medical prescription or control and there is little awareness about the adverse effects among the general public," it said, adding that no other country in the world has this combination. The sale of steroid creams is over half a billion-dollar business, with almost two-thirds of them sold without prescriptions.



    bacterial infectionsCDSCOCentral Drug Standards and Control OrganisationCentreChief Justice Gita MittalDelhi high courtDrugs and Cosmetics Actfairness creamfungal infectionsgovernmentIADVLJustice C Hari ShankarMeglow PremiumNoticepigmentationPILpleaprescriptionsPublic Interest LitigationSaleskin creamsskin diseasessteroids
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok